Y Intercept (Hong Kong) LTD Arcturus Therapeutics Holdings Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.37 Billion
- Q1 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 23,077 shares of ARCT stock, worth $274,847. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,077Holding current value
$274,847% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding ARCT
# of Institutions
161Shares Held
26.5MCall Options Held
312KPut Options Held
96.5K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$55.9 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$31.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.01MShares$23.9 Million0.23% of portfolio
-
Nikko Asset Management Americas, Inc.1.93MShares$22.9 Million0.27% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.93MShares$22.9 Million0.01% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $317M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...